Skip to content
TheChatArchiveThe Chat Archive
Claudeclaude-1· AnthropicHugging Face Arena Human Preference 55K

Explain the mechanism of action of a new checkpoint inhibitor mAb

From a Chatbot Arena battleThe same person sent this prompt to two anonymous models at once. Compare it with Claudeclaude-2.1’s answer.
  1. User

    Explain the mechanism of action of a new checkpoint inhibitor mAb

  2. Claude Assistant

    Checkpoint inhibitors are a class of immunotherapy drugs that work by blocking checkpoint proteins on immune cells called T-cells. These checkpoint proteins, such as PD-1 and CTLA-4, act as "brakes" on the immune system to prevent autoimmunity. However, tumors can exploit these checkpoints to evade detection and destruction by the immune system.

    Checkpoint inhibitor monoclonal antibodies work by blocking these inhibitory checkpoint proteins. For example, a PD-1 inhibitor blocks the PD-1 protein on T-cells, thereby releasing the brakes on the immune system and allowing T-cells to recognize and attack tumor cells. By blocking these checkpoint pathways, these drugs boost the anti-tumor immune response and enable the patient's own T-cells to kill cancer cells.

    Some key steps in the mechanism of action of a checkpoint inhibitor like a PD-1 mAb include:

    1. The mAb binds to the PD-1 receptor on T-cells, blocking its interaction with PD-L1 and PD-L2 ligands on tumor cells.

    2. With the PD-1/PD-L1 checkpoint pathway blocked, the inhibitory signal to the T-cell is eliminated. This activates the cytotoxic T-cells.

    3. The activated T-cells can now recognize tumor antigens and mount an anti-tumor immune response.

    4. The T-cells infiltrate the tumor microenvironment, recognize tumor cells and destroy them through direct killing as well as by secreting cytotoxic cytokines like IFN-gamma.

    5. This boosts the patient's own immune system to keep the tumor in check in a durable fashion. The effects can last for a long time after stopping the drug.

    So in summary, checkpoint inhibitors work by releasing the brakes on the immune system and boosting T-cell activation and the anti-tumor immune response. The activated T-cells can then kill tumor cells through direct cytotoxicity and orchestrating broader immune responses.

Responses were produced in different, uncontrolled contexts (system prompts, settings, prior turns). This is not a benchmark.